No Data
No Data
Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux
Express News | Edesa Biotech Inc - Appoints Peter J. Weiler as CFO Effective May 1, 2025
Express News | Edesa Biotech Announces Chief Financial Officer Transition
Press Release: Edesa Biotech Announces Chief Financial Officer Transition
H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $21
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)